Literature DB >> 21821494

SEOM clinical guidelines for hereditary cancer.

Begoña Graña1, Enrique Lastra, Gemma Llort, Joan Brunet, Dolores Isla.   

Abstract

Research in genetics has facilitated the identification of highly penetrant genes responsible for a large number of diseases. In the oncology field, genetic counselling and gene testing are focused on the two most common syndromes in familial cancer: hereditary breast and ovarian cancer syndrome (HBOC) and hereditary non-polyposis colorectal cancer or Lynch syndrome (LS). The objective of this guideline in hereditary cancer is to summarise the current state of knowledge and make recommendations in the areas of diagnosis, prevention and treatment of hereditary cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21821494     DOI: 10.1007/s12094-011-0701-2

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  24 in total

1.  Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study.

Authors:  Antonis C Antoniou; Matti Rookus; Nadine Andrieu; Richard Brohet; Jenny Chang-Claude; Susan Peock; Margaret Cook; D Gareth Evans; Rosalind Eeles; Catherine Nogues; Laurence Faivre; Paul Gesta; Flora E van Leeuwen; Margreet G E M Ausems; Ana Osorio; Trinidad Caldes; Jacques Simard; Jan Lubinski; Anne-Marie Gerdes; Edith Olah; Christine Fürhauser; Hakan Olsson; Brita Arver; Paolo Radice; Douglas F Easton; David E Goldgar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-02-03       Impact factor: 4.254

2.  Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Authors:  Susan M Domchek; Tara M Friebel; Christian F Singer; D Gareth Evans; Henry T Lynch; Claudine Isaacs; Judy E Garber; Susan L Neuhausen; Ellen Matloff; Rosalind Eeles; Gabriella Pichert; Laura Van t'veer; Nadine Tung; Jeffrey N Weitzel; Fergus J Couch; Wendy S Rubinstein; Patricia A Ganz; Mary B Daly; Olufunmilayo I Olopade; Gail Tomlinson; Joellen Schildkraut; Joanne L Blum; Timothy R Rebbeck
Journal:  JAMA       Date:  2010-09-01       Impact factor: 56.272

3.  Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.

Authors:  Noah D Kauff; Nandita Mitra; Mark E Robson; Karen E Hurley; Shaokun Chuai; Deborah Goldfrank; Eve Wadsworth; Johanna Lee; Tessa Cigler; Patrick I Borgen; Larry Norton; Richard R Barakat; Kenneth Offit
Journal:  J Natl Cancer Inst       Date:  2005-09-21       Impact factor: 13.506

4.  Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.

Authors:  Kathleen M Schmeler; Henry T Lynch; Lee-may Chen; Mark F Munsell; Pamela T Soliman; Mary Beth Clark; Molly S Daniels; Kristin G White; Stephanie G Boyd-Rogers; Peggy G Conrad; Kathleen Y Yang; Mary M Rubin; Charlotte C Sun; Brian M Slomovitz; David M Gershenson; Karen H Lu
Journal:  N Engl J Med       Date:  2006-01-19       Impact factor: 91.245

5.  Prediction of MLH1 and MSH2 mutations in Lynch syndrome.

Authors:  Judith Balmaña; David H Stockwell; Ewout W Steyerberg; Elena M Stoffel; Amie M Deffenbaugh; Julia E Reid; Brian Ward; Thomas Scholl; Brant Hendrickson; John Tazelaar; Lynn Anne Burbidge; Sapna Syngal
Journal:  JAMA       Date:  2006-09-27       Impact factor: 56.272

6.  Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.

Authors:  Susan M Domchek; Tara M Friebel; Susan L Neuhausen; Theresa Wagner; Gareth Evans; Claudine Isaacs; Judy E Garber; Mary B Daly; Rosalind Eeles; Ellen Matloff; Gail E Tomlinson; Laura Van't Veer; Henry T Lynch; Olufunmilayo I Olopade; Barbara L Weber; Timothy R Rebbeck
Journal:  Lancet Oncol       Date:  2006-03       Impact factor: 41.316

Review 7.  Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature.

Authors:  Alexander Liede; Beth Y Karlan; Steven A Narod
Journal:  J Clin Oncol       Date:  2004-02-15       Impact factor: 44.544

8.  Who should be sent for genetic testing in hereditary colorectal cancer syndromes?

Authors:  Henry T Lynch; C Richard Boland; Miguel A Rodriguez-Bigas; Christopher Amos; Jane F Lynch; Patrick M Lynch
Journal:  J Clin Oncol       Date:  2007-08-10       Impact factor: 44.544

9.  Meta-analysis of BRCA1 and BRCA2 penetrance.

Authors:  Sining Chen; Giovanni Parmigiani
Journal:  J Clin Oncol       Date:  2007-04-10       Impact factor: 44.544

10.  The prevalence of BRCA1 mutations among young women with triple-negative breast cancer.

Authors:  S R Young; Robert T Pilarski; Talia Donenberg; Charles Shapiro; Lyn S Hammond; Judith Miller; Karen A Brooks; Stephanie Cohen; Beverly Tenenholz; Damini Desai; Inuk Zandvakili; Robert Royer; Song Li; Steven A Narod
Journal:  BMC Cancer       Date:  2009-03-19       Impact factor: 4.430

View more
  6 in total

1.  Germline promoter hypermethylation in BRCA1 and BRCA2 genes is not present in hereditary breast cancer patients.

Authors:  M Rodríguez-Balada; B Roig; M Melé; M Salvat; L Martorell; J Borràs; J Gumà
Journal:  Clin Transl Oncol       Date:  2018-02-05       Impact factor: 3.405

2.  Identification of hereditary breast and ovarian cancer germline variants in Granada (Spain): NGS perspective.

Authors:  María Molina-Zayas; Carmen Garrido-Navas; Jose Luis García-Puche; Julian Barwell; Susana Pedrinaci; Margarita Martínez Atienza; Susana García-Linares; Tomás de Haro-Muñoz; Jose Antonio Lorente; M Jose Serrano; Antonio Poyatos-Andújar
Journal:  Mol Genet Genomics       Date:  2022-04-22       Impact factor: 2.980

3.  SEOM recommendations on the structure and operation of hereditary cancer genetic counseling units (HCGCUs).

Authors:  Enrique Lastra-Aras; Luis Robles-Díaz; Carmen Guillén-Ponce; Emilio Alba; Juan-Jesús Cruz
Journal:  Clin Transl Oncol       Date:  2012-08-22       Impact factor: 3.405

4.  Hereditary breast and ovarian cancer in Andalusian families: a genetic population study.

Authors:  Bella Pajares; Javier Porta; Jose María Porta; Cristina Fernández-de Sousa; Ignacio Moreno; Daniel Porta; Gema Durán; Tamara Vega; Inmaculada Ortiz; Carolina Muriel; Emilio Alba; Antonia Márquez
Journal:  BMC Cancer       Date:  2018-06-08       Impact factor: 4.430

Review 5.  BRCA Genetic Test and Risk-Reducing Salpingo-Oophorectomy for Hereditary Breast and Ovarian Cancer: State-of-the-Art.

Authors:  Masayuki Sekine; Koji Nishino; Takayuki Enomoto
Journal:  Cancers (Basel)       Date:  2021-05-23       Impact factor: 6.639

6.  BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?

Authors:  Bárbara Alemar; Cleandra Gregório; Josef Herzog; Camila Matzenbacher Bittar; Cristina Brinckmann Oliveira Netto; Osvaldo Artigalas; Ida Vanessa D Schwartz; Jordy Coffa; Suzi Alves Camey; Jeffrey Weitzel; Patricia Ashton-Prolla
Journal:  PLoS One       Date:  2017-11-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.